Guillain–Barré syndrome with unilateral peripheral facial and bulbar palsy in a child: A case report

Abstract

Guillain–Barré syndrome is characterized by progressive motor weakness, sensory changes, dysautonomia, and areflexia. Cranial nerve palsies are frequent in Guillain–Barré syndrome. Among cranial nerve palsies in Guillain–Barré syndrome, facial nerve palsy is the most common affecting around half of the cases. Facial palsy in Guillain–Barré syndrome is usually bilateral. We describe a pediatric Guillain–Barré syndrome variant presenting with unilateral peripheral facial palsy and dysphagia. A 5-year-old boy had progressive lower extremity weakness and pain 3 days prior to onset of unilateral peripheral facial palsy. On presentation, diagnosis of Guillain–Barré syndrome was supported by areflexia and albuminocytologic dissociation. His condition deteriorated with a decline in his respiratory effort and inability to handle secretions. He was given non-invasive ventilation to prevent worsening of his acute respiratory failure. Brain and spine magnetic resonance imaging scans showed enhancement of the left bulbar nerve complex and anterior and posterior cervical nerve roots with gadolinium. Treatment with intravenous immunoglobulin led to an uneventful clinical course with partial recovery within 2 weeks. In summary, Guillain–Barré syndrome should be considered as a possible cause of unilateral peripheral facial palsy. Guillain–Barré syndrome patients with facial nerve and bulbar palsy require close monitoring as they are at risk of developing acute respiratory failure. Early intervention with intravenous immunoglobulin may benefit these patients. Magnetic resonance imaging findings may lend support to early intervention.

Introduction

Guillain–Barré syndrome (GBS) is characterized by a classical triad of progressive motor weakness, areflexia, and albuminocytologic dissociation.¹ Cranial nerve palsies are frequent in GBS. Among cranial nerve palsies in GBS, facial nerve palsy is the most common affecting around half of the cases.^2,3 Facial palsy in GBS is usually bilateral and less frequently unilateral in adults.⁴ In children, cranial nerve involvement is less common than in adults.⁵ As in adults, facial palsy is most commonly bilateral. We are only able to find few reports of unilateral facial palsy in children.^3,6–10 We describe a child with GBS variant who had unilateral peripheral facial palsy and dysphagia.

Case report

A 5-year-old boy presented with a 7-day history of bilateral lower limb pain, irritability, difficulty walking, and loss of balance. He had fever and nasal congestion 2 weeks earlier. He was seen by primary care physician 4 days before admission for left facial droop and inability to close the left eye and was treated with oral antibiotics and prednisolone for presumed otitis media and Bell’s palsy. There was no history of vomiting, diarrhea, or abdominal pain. There was no recent vaccination, and immunizations were up-to-date.

On admission, he appeared alert, oriented, and nontoxic. Vital signs were normal. Higher mental function and language were appropriate for age. The cranial nerve examination showed left facial droop, effacement of left nasolabial fold while smiling, inability to close the left eye, raise the left eyebrow or frown; all consistent with Bell’s palsy. His muscle strength was 4/5 in upper and 3/5 in lower extremities and had generalized hypotonia. The position sensation was decreased and deep tendon reflexes (DTRs) were absent. He was able to sit on the side of the bed and stand while locking his knees, but he was unable to walk or raise the arms above the shoulder. The finger-to-nose and heel-to-shin tests showed dysmetria, and appendicular ataxia was present in all four limbs. His condition deteriorated with a decline in respiratory effort and inability to handle secretions. He was noted to have low tone voice with nasal intonation, dysphagia with drooling, and weak cough indicating bulbar palsy. He was given non-invasive ventilation to prevent worsening of his acute respiratory failure.

Complete blood count and comprehensive metabolic panel were normal. Multiplex polymerase chain reaction (BioFire Diagnostics, Salt Lake City, UT) was positive for coronavirus OC43. Cerebrospinal fluid (CSF) was clear, and CSF analysis showed albuminocytologic dissociation with no cells and elevated CSF total protein (248 mg/dL; reference ⩽45 mg/dL). He had elevated level of CSF immunoglobulin G (IgG) synthesis (86.5 mg/day; reference ⩽8 mg/day), albumin index (39.8; reference ⩽9), and IgG index (0.89; reference ⩽0.66). The CSF myelin basic protein level was normal (1.25 ng/mL; reference <4 ng/mL). There were no oligoclonal bands in CSF. Cultures of CSF, blood, and urine showed no pathogenic growth. Stool and CSF multiplex polymerase chain reaction panel (Biofire) and tests for Lyme disease, Bartonella henselae, Epstein–Barr virus, Mycoplasma, and Toxoplasma gondii were negative. Brain and spine magnetic resonance imaging (MRI) scans showed enhancement of the left bulbar nerve complex and anterior and posterior cervical nerve roots with gadolinium (Figure 1).

Figure 1.

Magnetic resonance imaging scan of the brain and spine. Axial T1-weighted images without and with gadolinium showing enhancement of the left cranial nerves X and XI (a, b) (long arrows) and anterior (arrowheads) and posterior cervical nerve roots (c–f) (short arrows).

The intravenous immunoglobulin (IVIG; 1 g/kg) was given on two consecutive days after CSF results confirmed the diagnosis of GBS. Forty-eight hours after the first IVIG infusion, improvement was noted in respiratory status, vocalization, and swallowing. Two weeks after admission, at discharge, he still required assistance during walking; however, his facial weakness was remarkably improved.

Discussion

The GBS in the present child was unusual because it was associated with unilateral peripheral facial nerve palsy. The incidence of GBS is 0.5–2 per 100,000 children <18 years.^11,12 It is an acute inflammatory demyelinating polyneuropathy (AIDP) characterized by progressive lower limb weakness that typically occurs after infection with Campylobacter jejuni, Mycoplasma pneumoniae, influenza virus, Epstein–Barr virus, or cytomegalovirus.¹³ Coronavirus infection as in our case is rarely associated with GBS.¹⁴

Neuroimaging has now become a valuable diagnostic tool in suspected pediatric GBS as postgadolinium enhancement of the peripheral nerve roots and cauda equina is seen on spinal MRI in as many as 95% children with GBS in the acute setting.^15–18 Enhancement of dorsal and ventral root is classically seen in AIDP.¹⁸ In acute motor axonal neuropathy (AMAN), enhancement is limited to the anterior roots.^19,20 In our case, AIDP is the most likely diagnosis as contrast-enhanced MRI of the cord revealed anterior and posterior root enhancement. Cranial nerve enhancement is reported in children with GBS variants such as Miller Fisher syndrome¹⁶ and polyneuritis cranialis²¹ as well as other variants.¹⁸ In our patient, enhancement of the seventh cranial nerve was not seen. Zuccoli et al.¹⁶ made the similar interesting observation that in spite of the common clinical involvement of the facial nerve, facial nerve enhancement is uncommon. Cranial nerve enhancement of cranial nerve X and XI was seen in our patient. The enhancement with gadolinium suggests inflammatory infiltrate on nerve sheaths and breakdown of the blood–brain barrier because of inflammation.²² Electrodiagnostic studies were not performed in our patient. We believe that it was not necessary as neuroimaging was diagnostic of AIDP. Electrodiagnostic studies are frequently challenging and unobtainable in children.

At the initial outpatient visit, the child was misdiagnosed with unilateral Bell’s palsy, and the bilateral lower limb symptoms were not recognized. In GBS, unilateral facial palsy simulating unilateral Bell’s palsy is a rare presenting symptom, especially in children; the literature search showed only five patients (Table 1). Four out of five previous cases were female. The pattern of onset of unilateral facial weakness in relation to GBS seems to be variable. The first case, a 2-year-old boy who had acute motor-sensory axonal GBS, presented with ataxia, dysesthesia and subsequently developed unilateral facial palsy.⁶ The second case was a 3-year-old girl who simultaneously had hypertension, unilateral facial palsy, and GBS with ataxia and areflexia.³ The third case was a 5-year-old girl who had hypertension and unilateral facial palsy 48 h prior to onset of GBS.³ The fourth case was an 11-year-old girl with left facial palsy 3 days prior to onset of full-blown GBS.¹⁰ The fifth case is a 15-year-old girl who presented with classic GBS and developed left-sided facial palsy 2 weeks after the onset of the symptoms.⁷

Table 1.

Published reports of unilateral facial palsy in children who had Guillain–Barré syndrome^a.

Age (y)	Sex	Timing of facial palsy onset	Follow-up	Reference
2	Male	48 h after GBS onset	Able to walk at 2-week, resolution of facial weakness at 2 months	Kamihiro et al.6
3	Female	Concomitant with GBS onsetb	Normal neurological examination at 3 months	Smith et al.3
5	Female	48 h before GBS onsetb	Normal neurological examination at 4 months	Smith et al.3
11	Female	3 days before GBS onset	Not available	Sinhabahu and Wijesekara10
15	Female	2 weeks after GBS onset	Normal facial examination at 2 months	Iqbal et al.7

GBS: Guillain–Barré syndrome.

^aLiterature search performed with PubMed and review of references in published studies.

^bPatient also had hypertension.

There are several theories about the cause of unilateral facial palsy in GBS. Facial palsy in childhood onset GBS may be caused by neural compression in narrow internal acoustic canal and may be aggravated by facial nerve edema and hemorrhage caused by hypertension.⁹ Similarly, it can be caused by antibody-mediated demyelination,²³ which is the possible explanation in our patient. Whether the cases of facial nerve palsy reported in children with GBS were caused by severe hypertension or were the first manifestation of the polyneuropathy remains uncertain. A review of past literature showed controversy regarding treatment of GBS with steroid.^24,25 Some suggest that GBS with peripheral facial palsy may require glucocorticoid therapy. Glucocorticoid therapy must be started early after onset of symptoms to shorten the time of recovery.^26–29 Facial palsy may resolve in 2 weeks with IVIG therapy.¹⁰

The bulbar palsy implies the involvement of lower cranial nerves IX, X, XI, and XII. In our patient, unilateral facial palsy and lower extremity weakness preceded the onset of bulbar palsy. This occurrence is rare even in the adult onset GBS.^22,23,30 In the pharyngeal–cervical–brachial variant of GBS, acute bulbar palsy with or without other cranial nerve involvement may occur in the absence of any limb weakness or ataxia.⁸ Unilateral facial palsy with bulbar weakness was reported in one pediatric case of pharyngeal-cervical-brachial variant.⁸ The bulbar palsy is as frequent as facial diplegia in GBS.³⁰ Bulbar palsy can occur together with other cranial nerve palsies, usually the facial nerve.^31,32 The atypical or GBS variants were noted to have rapid progression of disease than the typical GBS cases.³³ About 15%–20% of GBS cases who require mechanical ventilation were noted to have preceding dysphagia and facial weakness.³² Patients with signs of bulbar involvement such as difficulty swallowing, dysphonia, and/or shoulder weakness need close monitoring. Bulbar palsy indicates impending respiratory paralysis; therefore, respiratory support may be required.^30,32. In our present patient, IVIG resulted in rapid improvement of vocalization and swallowing ability. It is believed that IVIG reduces inflammation and modifies autoimmunity.

Conclusion

In pediatric patients with an atypical presentation, diagnosis of GBS is often delayed.³⁴ GBS should be considered as a possible cause of unilateral peripheral facial palsy. GBS patients with facial nerve palsy and bulbar weakness require close monitoring as they are at risk of developing acute respiratory failure. Early intervention with IVIG may benefit these patients. MRI findings may lend support to early intervention.